Acorah Software Products - Accounts Production 19.4.300 false true false true No description of principal activity 21 March 2025 31 March 2026 31 March 2026 16332369 Dr Arpeat Kaviya iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16332369 2025-03-20 16332369 2026-03-31 16332369 2025-03-21 2026-03-31 16332369 frs-core:CurrentFinancialInstruments 2026-03-31 16332369 frs-bus:PrivateLimitedCompanyLtd 2025-03-21 2026-03-31 16332369 frs-bus:FilletedAccounts 2025-03-21 2026-03-31 16332369 frs-bus:Micro-entities 2025-03-21 2026-03-31 16332369 frs-bus:AuditExempt-NoAccountantsReport 2025-03-21 2026-03-31 16332369 frs-bus:Director1 2025-03-21 2026-03-31
Registered number: 16332369
Drakav Ltd
Unaudited Financial Statements
For the Period 21 March 2025 to 31 March 2026
Nasa Accountants Limited
5th Floor Blok
1 Castle Park
Bristol
BS2 0JA
Balance Sheet
Registered number: 16332369
31 March 2026
£
Current assets 88,785
Creditors: Amounts Falling Due Within One Year (81,769 )
NET CURRENT ASSETS 7,016
TOTAL ASSETS LESS CURRENT LIABILITIES 7,016
NET ASSETS 7,016
CAPITAL AND RESERVES 7,016

Notes

1. General Information
Drakav Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16332369 . The registered office is Flat 95 North 5 Chicheley Street, London, SE1 7PN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Arpeat Kaviya
Director
16/09/2026